Real-world treatment patterns in newly diagnosed heart failure patients stratified by ejection fraction subtype in Japan

1 September 2025 (13:15 - 14:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Ms Rachel Knapp

Berlin (Germany)

7 More presentations in this session

Presentation thumbnail

EVOLUTION-HF DEallEF: a non-interventional study program of patients with heart failure and initiated on dapagliflozin: results of 1st interim analysis

Professor M. Paul (Muenster, DE)

Abstract Slides Video

Presentation thumbnail

Association between calcium channel blockers prescription and outcome according to left ventricular ejection fraction: data from a real-world heart failure population

Doctor M. Gori (Bergamo, IT)

Abstract Slides Video

Presentation thumbnail

Outpatient diuretic use in patients with baroreflex activation therapy

Doctor L. Straw (Columbia, US)

Abstract Slides Video

Presentation thumbnail

Active vs passive best-practice alerts to improve guideline-directed lipid-lowering therapy intensification in patients with recent myocardial infarction and elevated LDL-C

Doctor D. Karalis (Philadelphia, US)

Abstract Slides Video

Presentation thumbnail

Prognostic impact of maximum vasodilation therapy in heart failure

Doctor C. Santos Aragao (Aracaju, BR)

Abstract Slides Video

Access the full session

Session thumbnail

Heart failure in the real world

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET

You may be interested in

Congress Presentation

Real-life management of heart failure: evaluation of medication optimisation in different phenotypes.

Congress Presentation

Early initiation of disease-modifying therapy in patients with suspected heart failure

Congress Presentation

Clinical characteristics and outcomes in a cohort of patients starting treatment with vericiguat in the US.

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources